SCHEMBL11963701

SCHEMBL11963701

Cc1sc(-c2ccc(Cl)cc2)nc1C1C(=O)CC(Cc2ccccn2)C1=O

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HRH3 Q9Y5N1 5/20 0.39
▸ KMT2A Q03164 2/20 0.36
▸ SMN1; SMN2 Q16637 2/20 0.36
▸ APEX1 P27695 1/20 0.35
▸ NPC1 O15118 1/20 0.35
▸ RAB9A P51151 1/20 0.35
▸ PPARG P37231 1/20 0.35
▸ PPARA Q07869 1/20 0.35
▸ GAA P10253 1/20 0.34
▸ IKBKB O14920 2/20 0.34
▸ PRKAG1 P54619 2/20 0.34
▸ PRKAA1 Q13131 2/20 0.34
▸ NEK1 Q96PY6 2/20 0.34
▸ PRKAB1 Q9Y478 2/20 0.34
▸ MAPT P10636 3/20 0.34
▸ ALDH1A1 P00352 2/20 0.34
▸ KDM4E B2RXH2 1/20 0.34
▸ LMNA P02545 1/20 0.34
▸ TDP1 Q9NUW8 1/20 0.34
▸ MEN1 O00255 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11963675 0.92 SYK (0.37) KMT2ASMN1; SMN2NPC1RAB9APPARG
SCHEMBL1160501 0.85 HRH3 (0.38) HRH3KMT2ASMN1; SMN2APEX1NPC1
SCHEMBL427482 0.77 IKBKB (0.39) KMT2ASMN1; SMN2NPC1RAB9AIKBKB
SCHEMBL11963679 0.77 HCRTR1 (0.35) PPARGPPARAMAPT
SCHEMBL1160649 0.77 PDE1A (0.36) HRH3KMT2ASMN1; SMN2APEX1NPC1
SCHEMBL15001746 0.75 RAB9A (0.39) KMT2ANPC1RAB9AIKBKBPRKAG1
SCHEMBL427461 0.74 IKBKB (0.41) SMN1; SMN2GAAIKBKBPRKAG1PRKAA1
SCHEMBL1160374 0.73 RAB9A (0.43) HRH3KMT2ASMN1; SMN2APEX1NPC1
SCHEMBL16204000 0.73 KDM4E (0.39) KMT2ASMN1; SMN2NPC1RAB9AIKBKB
SCHEMBL16206279 0.73 POLB (0.39) NPC1IKBKBPRKAG1PRKAA1NEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2459547-B1 HERBICIDALLY ACTIVE HETEROARYL-SUBSTITUTED CYCLIC DIONES OR DERIVATIVES THEREOF SYNGENTA LTD (GB) 2016-04-20 — — EP disclosed
US-9051300-B2 Herbicides SYNGENTA LIMITED (GB) 2015-06-09 — — US disclosed
US-9051300-B2 Herbicides SYNGENTA LIMITED (GB) 2015-06-09 — — US disclosed
US-20120202691-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-08-09 — — US disclosed
US-20120202691-A1 NOVEL HERBICIDES SYNGENTA CROP PROTECTION LLC (US) 2012-08-09 — — US disclosed
WO-2011012862-A1 HERBICIDALLY ACTIVE HETEROARYL-SΥBSTITΥTED CYCLIC DIONES OR DERIVATIVES THEREOF SYNGENTA LIMITED (GB) 2011-02-03 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120202691-A1 NOVEL HERBICIDES DDT, HCN1, HDHD5 HRH3 905/4885KMT2A 344/4885SMN1; SMN2 3381/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback